HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FTC to collect 80% of proceeds from Pantron I founder's Ch. 7 bankruptcy liquidation.

This article was originally published in The Rose Sheet

Executive Summary

HELSINKI FORMULA SETTLEMENT WITH FTC MEANS PANTRON LIQUIDATION PROCEEDS will go to the commission, according to a final judgment and permanent injunction filed in Los Angeles federal court on Feb. 11 and announced by the Federal Trade Commission Feb. 12. The monetary settlement is intended to be used toward establishing a consumer redress program for purchasers of Pantron I's Helsinki Formula antibaldness product. The judgment also supports FTC's contention that Pantron made "false and deceptive" antibaldness claims for Helsinki Formula.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS003809

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel